Skyline Vet Pharma, Inc.

Skyline Vet Pharma, Inc.

Skyline Vet Pharma, Inc.

Overview
Date Founded

2015

Headquarters

37 Skyline Drive,Groton, CT 06340

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Pharmaceuticals
Holding Companies
Consumer Services
Hospitals & Patient Services
Agriculture & Mills

Company Description

Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT.

Executives & Employees

President & Chief Executive Officer

Chief Financial Officer, Director & Vice President

Board of Directors

Chief Executive Officer at Agtech Accelerator Corp.

EIR at Mountain Group Capital LLC

President & Chief Executive Officer at Skyline Vet Pharma, Inc.

Founder & General Partner at Taraval Associates LLC

Paths to Skyline Vet Pharma, Inc.
Potential Connections via
Relationship Science
You
Skyline Vet Pharma, Inc.
Recent Transactions
Details Hidden

Skyline Vet Pharma, Inc. raised money in a private placement transaction

Details Hidden

Skyline Vet Pharma, Inc. raised money in a private placement transaction

Investors
Details Hidden

AgTech Accelerator Corp. focuses on discovering and developing agricultural technology companies. It offers finance to agricultural firms. The company was founded in 2003 and is headquartered in Durham, NC.

Details Hidden

Syngenta Ventures invests in agricultural companies located globally. It provides financing from seed to larger growth stage capital requirements, with investment size ranging from $1 to $5 million per company. It also takes seat in board.

Details Hidden

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Skyline Vet Pharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Skyline Vet Pharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Skyline Vet Pharma, Inc..